Mohamed Magdy Badr: Calciphylaxis – The Silent Killer in Kidney Failure
Mohamed Magdy Badr, Wound Care Consultant at Armed Force Rehabilitation Center, posted on LinkedIn:
”Calciphylaxis: The Silent Killer in Kidney Failure
A rare but devastating vascular-cutaneous emergency that every clinician must recognize early.
What Is Calciphylaxis?
Calciphylaxis is a life-threatening syndrome caused by progressive calcification, thrombosis, and occlusion of small dermal and subcutaneous arterioles.
The result? Severe ischemia → deep necrosis → non-healing ulcers with extremely high mortality.
Who Is at Risk?
- Most commonly seen in patients with:
- End-Stage Renal Disease (ESRD) on dialysis
- Disturbed calcium–phosphate balance
- High PTH (secondary hyperparathyroidism)
- Diabetes, obesity, liver disease
- Warfarin therapy
- Low serum albumin
How It Presents Clinically
Calciphylaxis lesions typically evolve through:
- Painful violaceous livedo reticularis
- Indurated plaques or nodules
- Ulceration with black eschar (necrosis)
- Risk of rapid infection, sepsis, and limb loss
Key red flag: Pain is often out of proportion to the visible lesion.
Common sites: thighs, abdomen, buttocks, legs—areas rich in adipose tissue.
Diagnosis
- Primarily clinical, supported by:
- Elevated Ca × PO₄ product
- Increased PTH
- Imaging showing soft-tissue calcification
- Biopsy only when necessary (may worsen the wound)
Management: Multidisciplinary and Urgent
Successful management requires rapid, coordinated intervention:
1. Correct Mineral Imbalance
- Phosphate binders
- Aggressive control of Ca/PO₄
- Cinacalcet for PTH regulation
2. Discontinue Warfarin
- One of the most evidence-based steps.
3. Sodium Thiosulfate
- IV infusion after hemodialysis—now a cornerstone therapy.
4. Optimal Wound Care
- Gentle debridement
- Infection prevention
- Moisture balance
- Pain management (often severe)
5. Consider Parathyroidectomy
- For refractory secondary hyperparathyroidism.
Prognosis
- Mortality remains 50–80%, mainly due to sepsis.
- Early detection and aggressive treatment dramatically improve survival.
Take-Home Message
- Any dialysis patient with severe, disproportionate pain, violaceous patches, or evolving necrotic ulcers should raise immediate suspicion for calciphylaxis.
- Early recognition = better outcomes.
- Delayed recognition = catastrophic consequences.”

Stay informed with Hemostasis Today.
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology
-
Feb 23, 2026, 15:20Rabab Al Dawood: Moderating the Coagulation and Hemostasis Session at the ISLH 1st Joint Conference
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline